ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California. Show more

Location: 12526 High Bluff Drive, San Diego, CA, 92130, United States | Website: https://www.inmagenebio.com | Industry: Biotechnology | Sector: Healthcare


Market Cap

65.41M

52 Wk Range

$5.76 - $20.40

Previous Close

$5.90

Open

$5.84

Volume

78,375

Day Range

$5.76 - $6.16

Enterprise Value

-73.73M

Cash

142.6M

Avg Qtr Burn

-11.03M

Insider Ownership

14.68%

Institutional Own.

44.62%

Qtr Updated

09/30/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date